As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a ‘free’ updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

Europe diagnostics market is expected to grow at an impressive rate during the forecast period. The Europe diagnostics market is driven by the changing dietary habits and lifestyle patterns. Increasing consumption of alcohol, tobacco, junk food has led to the growing prevalence of chronic diseases such as cancer, respiratory disorders, renal diseases, diabetes, cardiovascular diseases, among others. This in turn has increased the patient pool, thereby increasing population base going for diagnostic tests. Additionally, growing awareness pertaining to healthcare and availability of health insurance policies is further expected to propel the market growth through 2025. Furthermore, growing popularity of personalized medicine is expected to create lucrative opportunities for market growth over the next few years. Besides, the sudden outbreak and spread of pandemic COVID-19 with European countries such as Italy and Spain being adversely impacted by the pandemic, is expected to positively influence the market growth.

The Europe diagnostics market is segmented based on product type, type of test, technique, usability, application, end user, company and region. Based on product type, the market can be categorized into reagents, instruments and software & services. Among these, the reagents segment is expected to dominate the market during the forecast period owing to increasing number of diagnostic tests being performed in labs, which have increased the demand for reagents. Based on application, the market can be divided into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases and others. Out of these, the infectious diseases segment is expected to dominate the market owing to the increasing awareness among the population pertaining to spread of various infectious diseases and their growing prevalence. Furthermore, the outbreak and spread of pandemic COVID-19, which is also an infectious disease, is expected to drive the segmental growth through 2025.

Major players operating in the Europe diagnostics market include Roche Diagnostics, Alere, Inc., Abbott Laboratories, Inc., Hologic, Inc. (Gen-Probe), Qiagen N.V., Bio-Rad Laboratories, Inc., Quidel Corporation, Becton, Dickinson (BD) Company, Inc., bioMerieux, Inc., Siemens Healthcare GmbH and others. The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and estimate the market size of Europe diagnostics market from 2015 to 2018.
  • To estimate and forecast the market size of Europe diagnostics market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast Europe diagnostics market based on product type, type of test, technique, usability, application, end user, company and country distribution.
  • To identify dominant country or segment in the Europe diagnostics market.
  • To identify drivers and challenges for Europe diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Europe diagnostics market.
  • To identify and analyze the profile of leading players operating in Europe diagnostics market.
  • To conduct pricing analysis in the Europe diagnostics market.
  • To identify key sustainable strategies adopted by market players in Europe diagnostics market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of major diagnostic players and hospital chains across the region. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the diagnostic players and hospital chains which could not be identified due to the limitations of secondary research. TechSci Research analyzed the diagnostic players and hospital chains, labs and presence of all major players across the region.

TechSci Research calculated the market size of Europe diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Diagnostics hospitals, laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to diagnostics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals, laboratories, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Europe diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Europe Diagnostics Market, By Product Type:
    • Reagents
    • Instruments
    • Software & Services
  • Europe Diagnostics Market, By Type of Test:
    • Lipid Panel
    • Metabolic Panel
    • Infectious Disease Testing
    • Others
  • Europe Diagnostics Market, By Technique:
    • Immunodiagnostics
    • Molecular Diagnostics
    • Tissue Diagnostics
    • Clinical Techniques
    • Others
  • Europe Diagnostics Market, By Usability:
    • Reusable
    • Disposable
  • Europe Diagnostics Market, By Application:
    • Infectious Diseases
    • Cancer
    • Cardiac Diseases
    • Immune System Disorders
    • Nephrological Diseases
    • Gastrointestinal Diseases
    • Others
  • Europe Diagnostics Market, By End User:
    • Hospitals & Clinics
    • Diagnostic Centers
    • Point-of-Care Testing Centers
    • Private or Commercial Laboratories
    • Others
  • Europe Diagnostics Market, By Country:
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Switzerland
    • Russia
    • Sweden
    • Denmark
    • Netherlands

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Europe diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Europe diagnostics market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Europe Diagnostics Market

4.    Executive Summary

5.    Voice of Customer

6.    Europe Diagnostics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product Type (Reagents, Instruments, Software & Services)

6.2.2.     By Type of Test (Lipid Panel, Metabolic Panel, Infectious Disease Testing, Others)

6.2.3.     By Technique (Immunodiagnostics, Molecular Diagnostics, Tissue Diagnostics, Clinical Techniques, Others)

6.2.4.     By Usability (Reusable v/s Disposable)

6.2.5.     By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others)

6.2.6.     By End User (Hospitals & Clinics, Diagnostic Centers, Point-of-Care Testing Centers, Private or Commercial Laboratories, Others)

6.2.7.     By Company (2019)

6.2.8.     By Country

6.3.  Product Market Map

6.4.  Europe: Country Analysis

6.4.1.     Russia & CIS Diagnostics Market Outlook

6.4.1.1.         Market Size & Forecast

6.4.1.1.1.             By Value

6.4.1.2.         Market Share & Forecast

6.4.1.2.1.             By Product Type

6.4.1.2.2.             By Type of Test

6.4.1.2.3.             By Technique

6.4.1.2.4.             By Usability

6.4.1.2.5.             By Application

6.4.1.2.6.             By End User

6.4.2.     France Diagnostics Market Outlook

6.4.2.1.         Market Size & Forecast

6.4.2.1.1.             By Value

6.4.2.2.         Market Share & Forecast

6.4.2.2.1.             By Product Type

6.4.2.2.2.             By Type of Test

6.4.2.2.3.             By Technique

6.4.2.2.4.             By Usability

6.4.2.2.5.             By Application

6.4.2.2.6.             By End User

6.4.3.     Germany Diagnostics Market Outlook

6.4.3.1.         Market Size & Forecast

6.4.3.1.1.             By Value

6.4.3.2.         Market Share & Forecast

6.4.3.2.1.             By Product Type

6.4.3.2.2.             By Type of Test

6.4.3.2.3.             By Technique

6.4.3.2.4.             By Usability

6.4.3.2.5.             By Application

6.4.3.2.6.             By End User

6.4.4.     United Kingdom Diagnostics Market Outlook

6.4.4.1.         Market Size & Forecast

6.4.4.1.1.             By Value

6.4.4.2.         Market Share & Forecast

6.4.4.2.1.             By Product Type

6.4.4.2.2.             By Type of Test

6.4.4.2.3.             By Technique

6.4.4.2.4.             By Usability

6.4.4.2.5.             By Application

6.4.4.2.6.             By End User

6.4.5.     Italy Diagnostics Market Outlook

6.4.5.1.         Market Size & Forecast

6.4.5.1.1.             By Value

6.4.5.2.         Market Share & Forecast

6.4.5.2.1.             By Product Type

6.4.5.2.2.             By Type of Test

6.4.5.2.3.             By Technique

6.4.5.2.4.             By Usability

6.4.5.2.5.             By Application

6.4.5.2.6.             By End User

6.4.6.     Spain Diagnostics Market Outlook

6.4.6.1.         Market Size & Forecast

6.4.6.1.1.             By Value

6.4.6.2.         Market Share & Forecast

6.4.6.2.1.             By Product Type

6.4.6.2.2.             By Type of Test

6.4.6.2.3.             By Technique

6.4.6.2.4.             By Usability

6.4.6.2.5.             By Application

6.4.6.2.6.             By End User

6.4.7.     Switzerland Diagnostics Market Outlook

6.4.7.1.         Market Size & Forecast

6.4.7.1.1.             By Value

6.4.7.2.         Market Share & Forecast

6.4.7.2.1.             By Product Type

6.4.7.2.2.             By Type of Test

6.4.7.2.3.             By Technique

6.4.7.2.4.             By Usability

6.4.7.2.5.             By Application

6.4.7.2.6.             By End User

6.4.8.     Netherlands Diagnostics Market Outlook

6.4.8.1.         Market Size & Forecast

6.4.8.1.1.             By Value

6.4.8.2.         Market Share & Forecast

6.4.8.2.1.             By Product Type

6.4.8.2.2.             By Type of Test

6.4.8.2.3.             By Technique

6.4.8.2.4.             By Usability

6.4.8.2.5.             By Application

6.4.8.2.6.             By End User

6.4.9.     Denmark Diagnostics Market Outlook

6.4.9.1.         Market Size & Forecast

6.4.9.1.1.             By Value

6.4.9.2.         Market Share & Forecast

6.4.9.2.1.             By Product Type

6.4.9.2.2.             By Type of Test

6.4.9.2.3.             By Technique

6.4.9.2.4.             By Usability

6.4.9.2.5.             By Application

6.4.9.2.6.             By End User

6.4.10.  Sweden Diagnostics Market Outlook

6.4.10.1.      Market Size & Forecast

6.4.10.1.1.           By Value

6.4.10.2.      Market Share & Forecast

6.4.10.2.1.           By Product Type

6.4.10.2.2.           By Type of Test

6.4.10.2.3.           By Technique

6.4.10.2.4.           By Usability

6.4.10.2.5.           By Application

6.4.10.2.6.           By End User

7.    Market Dynamics

7.1.  Drivers

7.2.  Challenges

8.    Market Trends & Developments

9.    Country-Wise Approved Supplier of Diagnostics Kits Supplier

10.  Competitive Landscape

10.1.              Roche Diagnostics

10.2.              Alere, Inc.

10.3.              Abbott Laboratories, Inc.

10.4.              Hologic, Inc. (Gen-Probe)

10.5.              Qiagen N.V.

10.6.              Bio-Rad Laboratories, Inc.

10.7.              Quidel Corporation

10.8.              Becton, Dickinson (BD) Company, Inc.

10.9.              bioMerieux, Inc.

10.10.            Siemens Healthcare GmbH

11.  Strategic Recommendations

12.  About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com